87 related articles for article (PubMed ID: 20429264)
21. Short-term effects of the TNFalpha antagonist infliximab on the acute phase reaction and activities of daily life in patients with rheumatoid arthritis.
Arvidson NG; Larsen A; Aaseth J; Larsson A
Scand J Clin Lab Invest; 2007; 67(3):337-42. PubMed ID: 17454848
[TBL] [Abstract][Full Text] [Related]
22. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
[No Abstract] [Full Text] [Related]
23. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
24. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial.
Häuselmann HJ; Caravatti M; Seifert B; Wang K; Bruckner P; Stucki G; Michel BA
Br J Rheumatol; 1998 Oct; 37(10):1110-7. PubMed ID: 9825751
[TBL] [Abstract][Full Text] [Related]
25. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
26. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
Durez P; Nzeusseu Toukap A; Lauwerys BR; Manicourt DH; Verschueren P; Westhovens R; Devogelaer JP; Houssiau FA
Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
[TBL] [Abstract][Full Text] [Related]
27. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
28. Osteocalcin in patients with rheumatoid arthritis. A one-year followup study.
Franck H; Ittel TH; Tasch O; Herborn G; Rau R
J Rheumatol; 1994 Jul; 21(7):1256-9. PubMed ID: 7966066
[TBL] [Abstract][Full Text] [Related]
29. Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis?
Ang HT; Helfgott S
J Rheumatol; 2003 Nov; 30(11):2315-8. PubMed ID: 14677170
[TBL] [Abstract][Full Text] [Related]
30. [Garlic effectiveness in rheumatoid arthritis].
Denisov LN; Andrianova IV; Timofeeva SS
Ter Arkh; 1999; 71(8):55-8. PubMed ID: 10515039
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study of the acute phase reaction. Acute phase proteins and a chronic inflammation, rheumatoid arthritis].
Shiokawa Y
Nihon Rinsho; 1987 May; 45(5):1068-75. PubMed ID: 2442435
[No Abstract] [Full Text] [Related]
32. [New classification criteria for rheumatoid arthritis].
Scirè CA; Caporali R
Reumatismo; 2010; 62(3):159-62. PubMed ID: 21052562
[No Abstract] [Full Text] [Related]
33. Disease-modifying antirheumatic drugs increase serum adiponectin levels in patients with rheumatoid arthritis.
Cansu B; Cansu DU; Kaşifoğlu T; Gülbas Z; Korkmaz C
J Clin Rheumatol; 2011 Jan; 17(1):14-7. PubMed ID: 21169855
[TBL] [Abstract][Full Text] [Related]
34. Combined measurement of multiple acute phase reactants to predict relapse of rheumatoid arthritis.
Lv F; Song LJ; Li XF
Int J Rheum Dis; 2015 Sep; 18(7):725-30. PubMed ID: 24131533
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics.
Pullerits R; Urbonaviciute V; Voll RE; Forsblad-D'Elia H; Carlsten H
J Rheumatol; 2011 Jul; 38(7):1523-5. PubMed ID: 21724730
[No Abstract] [Full Text] [Related]
36. The story behind the acute-phase reactants.
Amezcua-Guerra LM; Castillo-Martinez D; Bojalil R
J Rheumatol; 2010 Feb; 37(2):469; author reply 470. PubMed ID: 20147484
[No Abstract] [Full Text] [Related]
37. Concordant message of different inflammatory markers in patients with rheumatoid arthritis.
Arvidsson NG; Gudbjörnsson B; Hällgren R; Larsson A
Ups J Med Sci; 1998; 103(1):35-42. PubMed ID: 9789970
[TBL] [Abstract][Full Text] [Related]
38. [Clinical observation of compound xiatianwu tablets in treatment of 120 cases with active rheumatoid arthritis].
Yu SY; Yu ZA
Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(6):899-901. PubMed ID: 23717976
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis.
Dixon JS; Bird HA; Sitton NG; Pickup ME; Wright V
Scand J Rheumatol; 1984; 13(1):39-44. PubMed ID: 6202005
[TBL] [Abstract][Full Text] [Related]
40. Systemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatoid arthritis.
Luqmani R; Sheeran T; Robinson M; Richardson K; Winkles J; Emery P
Clin Exp Rheumatol; 1994; 12(5):503-8. PubMed ID: 7842530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
